
comment-analysis
Bernard Mallee: Coronavirus shows our reliance on biopharma
The industry is devoting all its resources to finding a vaccine, but we should not be complacent about the need to invest in future innovation, says
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC